...
首页> 外文期刊>The journal of clinical psychiatry >Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder
【24h】

Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder

机译:Venlafaxine单独与Venlafaxine加上强光疗法联合治疗严重抑郁症的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Phototherapy, ie, bright light therapy, is an effective and safe treatment of major depressive disorder (MDD). It exerts rapid mood-elevating activity, similar to antidepressant medications, most likely mediated through both monoaminergic and circadian system melatonergic mechanisms. We assessed the efficiency of bright light therapy as an adjuvant treatment to antidepressant pharmacotherapy in patients with severe MDD randomized by Hamilton Depression Rating Scale (HDRS) score to either (1) 150 mg venlafaxine hydrochloride daily at 7: 00 am or (2) 150 mg venlafaxine plus 60-minute light of 7000 lux the initial week of clinical management (venlafaxine + bright light therapy) daily at 7: 00 am.
机译:目的:光疗法,即强光疗法,是一种有效且安全的治疗重度抑郁症的方法。它具有与抗抑郁药类似的快速情绪提升活动,最有可能通过单胺能和昼夜节律性黑素能机制介导。我们通过汉密尔顿抑郁量表(HDRS)评分将重度MDD患者随机分配为(1)150 mg盐酸文拉法辛每天7:00或(2)150,评估强光疗法作为抗抑郁药物疗法辅助治疗的有效性在临床治疗的最初一周(文拉法辛+强光疗法)每天早上7:00毫克文拉法辛加60分钟的7000 lux光照。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号